Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab: Predictive Value of Sarcopenia in mRCC. (2025). Radiology and Oncology, 59(4), 624-634. https://www.radioloncol.com/index.php/ro/article/view/4685